OncLiveDr. Gomella on Ongoing Trials of Immunotherapy in Bladder CancerOncLiveLeonard Gomella, MD, professor, chair, Department of Oncology, director, Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses ongoing trials of immun… Continue reading
Gizmodo |
Gene-Editing Alternative Corrects Duchenne Muscular Dystrophy
Drug Discovery & Development Using the new gene-editing enzyme CRISPR–Cpf1, researchers at UT Southwestern Medical Center have successfully corrected Duchenne muscular dystrophy in human cells and mice in the lab. The UT Southwestern group had previously used … A New Flavor of CRISPR Could Tackle Some of the Worst Genetic DiseasesGizmodo CRISPR Corrects Duchenne-Causing MutationsThe Scientist Accurate DNA misspelling correction methodPhys.Org Civil Eats all 34 news articles » |
Newsweek |
Spray-On Skin: ‘Miracle’ Stem Cell Treatment Heals Burns Without Scarring
Newsweek The treatment, developed by German researcher Dr. Jörg Gerlach, was the world’s first to use a patient’s stem cells to directly heal the skin. If successful, the device would mend Uram’s wounds using his body’s ability to regenerate fully functioning skin. |
|
BRIEF-Crispr, Intellia, Caribou Biosciences, ERS Genomics announce appeal of CRISPR/CAS9 US patent board …
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … |
Gizmodo |
UC appeals US patent board decision on CRISPR-Cas9
UC Berkeley “Ultimately, we expect to establish definitively that the team led by Jennifer Doudna and Emmanuelle Charpentier was the first to engineer CRISPR-Cas9 for use in all types of environments, including in non-cellular settings and within plant, animal and … A New Flavor of CRISPR Could Tackle Some of the Worst Genetic DiseasesGizmodo CRISPR Has a Terrible NameThe Atlantic CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR …GlobeNewswire (press release) WebMD –The Scientist –Reuters all 36 news articles » |